Bruker (BRKRP) Cash & Equivalents Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | - | - | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.15% |
| Dec 31, 2025 | -15.21% |
| Sep 30, 2025 | -12.37% |
| Jun 30, 2025 | -14.58% |
| Mar 31, 2025 | -25.37% |
| Dec 31, 2024 | -23.02% |
| Sep 30, 2024 | -12.95% |
| Jun 30, 2024 | -9.69% |
| Mar 31, 2024 | 2.62% |
| Dec 31, 2023 | 8.66% |
| Sep 30, 2023 | 6.13% |
| Jun 30, 2023 | 17.31% |
| Mar 31, 2023 | 16.06% |
| Dec 31, 2022 | 14.71% |
| Sep 30, 2022 | 18.87% |
| Jun 30, 2022 | 27.13% |
| Dec 31, 2021 | 25.55% |
| Sep 30, 2021 | 15.51% |
| Mar 31, 2021 | 27.12% |
| Dec 31, 2020 | 176.75% |
| Sep 30, 2020 | 11.37% |
| Jun 30, 2020 | -8.81% |
| Mar 31, 2020 | 18.92% |
| Dec 31, 2019 | 16.25% |
| Sep 30, 2019 | -2.08% |
| Jun 30, 2019 | -6.24% |
| Mar 31, 2019 | -8.03% |
| Dec 31, 2018 | -5.97% |
| Sep 30, 2018 | -2.52% |
| Jun 30, 2018 | 0.61% |
| Mar 31, 2018 | 1.05% |
| Dec 31, 2017 | 0.91% |
| Sep 30, 2017 | 1.74% |
| Jun 30, 2017 | -1.96% |
| Dec 31, 2016 | 6.84% |
| Sep 30, 2016 | 7.32% |
| Mar 31, 2016 | 1.66% |
| Dec 31, 2015 | -55.11% |
| Sep 30, 2015 | 11.98% |
| Jun 30, 2015 | 11.33% |
| Mar 31, 2015 | 10.49% |
| Dec 31, 2014 | 9.06% |